摘要
目的研究临床药师在骨肉瘤患者手术后多柔比星+顺铂(AP)方案化疗的药学监护切入点。方法针对骨肉瘤患者术后AP方案化疗过程,进行化疗方案评价,对癌痛治疗提供建议,监测并预防药物不良反应的发生,对患者进行用药教育。结果通过临床药师的药学监护,患者化疗过程中获得个体化的治疗方案,提高药物治疗效果,减少药物损害。结论对于肿瘤患者建立和完善药学监护要点,可促进多学科综合治疗模式的发展,最终提高患者的生活质量。
Objective To investigate the pharmaceutical care towards postoperative inpatients with osteosarcoma receiving the AP chemotherapy regimen. Methods Individual patient care was established by evaluating chemotherapy regimen,offering suggestion in pain management,monitoring drug adverse reaction and performing medication education to the patient. Results The pharmaceutical care by clinical pharmacist provided individual chemotherapy,and improved the safety and therapeutic outcomes of drug regimen. Conclusion A multidisciplinary cancer care could be developed,and consequently the patient＇s quality of life will be improved by establishing pharmaceutical care for cancer patients.
出处
《医药导报》
CAS
2010年第10期1363-1365,共3页
Herald of Medicine
关键词
临床药师
药学监护
骨肉瘤
化疗
Clinical pharmacist
charmaceutical care
Osteosarcoma
Chemotherapy
